• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌细胞中雄激素受体基因转录本的RNA编辑

RNA editing of androgen receptor gene transcripts in prostate cancer cells.

作者信息

Martinez Harryl D, Jasavala Rohini J, Hinkson Izumi, Fitzgerald Latricia D, Trimmer James S, Kung Hsing-Jien, Wright Michael E

机构信息

University of California Davis Genome Center, Department of Pharmacology, School of Medicine, University of California, Sacramento, California 95817, USA.

出版信息

J Biol Chem. 2008 Oct 31;283(44):29938-49. doi: 10.1074/jbc.M800534200. Epub 2008 Aug 14.

DOI:10.1074/jbc.M800534200
PMID:18708348
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2662061/
Abstract

Reactivation of the androgen receptor (AR) signaling pathway represents a critical step in the growth and survival of androgen-independent (AI) prostate cancer (CaP). In this study we show the DU145 and PC3 AI human CaP cell lines respond to androgens and require AR expression for optimal proliferation in vitro. Interestingly, AR gene transcripts in DU145 and PC3 cells harbored a large number of single base pair nucleotide transitions that resulted in missense mutations in selected AR codons. The most notable lesion detected in AR gene transcripts included the oncogenic codon 877T-->A gain-of-function mutation. Surprisingly, AR gene transcript nucleotide transitions were not genome-encoded substitutions, but instead the mutations co-localized to putative A-to-I, U-to-C, C-to-U, and G-to-A RNA editing sites, suggesting the lesions were mediated through RNA editing mechanisms. Higher levels of mRNA encoding the A-to-I RNA editing enzymes ADAR1 and ADARB1 were observed in DU145 and PC3 cells relative to the androgen-responsive LNCaP and 22Rv1 human CaP cell lines, which correlated with higher levels of AR gene transcript A-to-I editing detected in DU145 and PC3 cells. Our results suggest that AR gene transcripts are targeted by different RNA editing enzymes in DU145 and PC3 cells. Thus RNA editing of AR gene transcripts may contribute to the etiology of hormone-refractory phenotypes in advanced stage AI CaP.

摘要

雄激素受体(AR)信号通路的重新激活是雄激素非依赖性(AI)前列腺癌(CaP)生长和存活的关键步骤。在本研究中,我们发现DU145和PC3这两种AI人CaP细胞系对雄激素有反应,且在体外最佳增殖需要AR表达。有趣的是,DU145和PC3细胞中的AR基因转录本存在大量单碱基对核苷酸转换,导致所选AR密码子出现错义突变。在AR基因转录本中检测到的最显著损伤包括致癌密码子877T→A功能获得性突变。令人惊讶的是,AR基因转录本核苷酸转换并非基因组编码的替代,而是这些突变共定位于假定的A到I、U到C、C到U和G到A的RNA编辑位点,这表明这些损伤是通过RNA编辑机制介导的。相对于雄激素反应性LNCaP和22Rv1人CaP细胞系,在DU145和PC3细胞中观察到编码A到I RNA编辑酶ADAR1和ADARB1的mRNA水平更高,这与在DU145和PC3细胞中检测到的更高水平的AR基因转录本A到I编辑相关。我们的结果表明,DU145和PC3细胞中的AR基因转录本被不同的RNA编辑酶靶向。因此,AR基因转录本的RNA编辑可能促成晚期AI CaP中激素难治性表型的病因。

相似文献

1
RNA editing of androgen receptor gene transcripts in prostate cancer cells.前列腺癌细胞中雄激素受体基因转录本的RNA编辑
J Biol Chem. 2008 Oct 31;283(44):29938-49. doi: 10.1074/jbc.M800534200. Epub 2008 Aug 14.
2
Androgenic up-regulation of androgen receptor cDNA expression in androgen-independent prostate cancer cells.雄激素非依赖性前列腺癌细胞中雄激素受体cDNA表达的雄激素上调。
Steroids. 1996 Sep;61(9):531-9. doi: 10.1016/s0039-128x(96)00086-4.
3
Sensitization of androgen refractory prostate cancer cells to anti-androgens through re-expression of epigenetically repressed androgen receptor - Synergistic action of quercetin and curcumin.通过表观遗传抑制的雄激素受体的重新表达使雄激素难治性前列腺癌细胞对抗雄激素敏感 - 槲皮素和姜黄素的协同作用。
Mol Cell Endocrinol. 2016 Aug 15;431:12-23. doi: 10.1016/j.mce.2016.04.024. Epub 2016 Apr 28.
4
Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.雄激素受体作为 ZEB2 表达的调节剂及其在前列腺癌上皮间质转化中的意义。
Endocr Relat Cancer. 2014 May 8;21(3):473-86. doi: 10.1530/ERC-13-0514. Print 2014 Jun.
5
Expression profiles and functional associations of endogenous androgen receptor and caveolin-1 in prostate cancer cell lines.雄激素受体和窖蛋白-1在前列腺癌细胞系中的表达谱和功能相关性。
Prostate. 2014 May;74(5):478-87. doi: 10.1002/pros.22767. Epub 2013 Dec 24.
6
Increased Akt signaling resulting from the loss of androgen responsiveness in prostate cancer.前列腺癌中由于雄激素反应丧失导致 Akt 信号转导增加。
Curr Med Chem. 2013;20(1):144-57.
7
PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor.PC3人前列腺癌细胞保留了雄激素受体发挥肿瘤抑制能力所需的共调节因子,而DU145人前列腺癌细胞则不然。
Prostate. 2006 Sep 1;66(12):1329-38. doi: 10.1002/pros.20483.
8
Comparison of prostate cancer cell lines for androgen receptor-mediated reporter gene assays.用于雄激素受体介导的报告基因检测的前列腺癌细胞系比较。
Toxicol In Vitro. 2006 Oct;20(7):1159-67. doi: 10.1016/j.tiv.2006.03.003. Epub 2006 Mar 8.
9
The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor.前列腺癌上调的长非编码 RNA PlncRNA-1 通过雄激素受体的相互调节调节细胞凋亡和增殖。
Urol Oncol. 2013 Oct;31(7):1117-23. doi: 10.1016/j.urolonc.2011.11.030. Epub 2012 Jan 20.
10
Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.威尔姆斯肿瘤抑制基因WT1对雄激素信号通路的转录调控。
Anticancer Res. 2001 Jan-Feb;21(1A):1-10.

引用本文的文献

1
Anticancer Effects of Ascorbic Acid: Not All Sides Fit All.抗坏血酸的抗癌作用:并非一概而论。
Cancers (Basel). 2025 Sep 1;17(17):2877. doi: 10.3390/cancers17172877.
2
Immunomodulatory role of RNA modifications in sex hormone-dependent cancers.RNA修饰在性激素依赖性癌症中的免疫调节作用。
Front Immunol. 2025 May 8;16:1513037. doi: 10.3389/fimmu.2025.1513037. eCollection 2025.
3
Characterization of RNA editing gene APOBEC3C as a candidate tumor suppressor in prostate cancer.RNA编辑基因载脂蛋白B mRNA编辑酶催化多肽样3C(APOBEC3C)作为前列腺癌候选肿瘤抑制因子的特征分析
Sci Rep. 2025 May 22;15(1):17725. doi: 10.1038/s41598-025-00169-1.
4
A-to-I RNA edited POLA2 attains carcinogenesis in prostatic cancer by impeding immune infiltration and upregulating BTBD7.A到I RNA编辑的POLA2通过阻碍免疫浸润和上调BTBD7在前列腺癌中实现致癌作用。
Discov Oncol. 2025 May 14;16(1):759. doi: 10.1007/s12672-025-02449-8.
5
Advances in Detection Methods for A-to-I RNA Editing.A-to-I RNA编辑检测方法的进展
Wiley Interdiscip Rev RNA. 2025 Mar-Apr;16(2):e70014. doi: 10.1002/wrna.70014.
6
Recent Advances in Adenosine-to-Inosine RNA Editing in Cancer.癌症中腺苷到肌苷 RNA 编辑的最新进展。
Cancer Treat Res. 2023;190:143-179. doi: 10.1007/978-3-031-45654-1_5.
7
Clinical relevance of RNA editing profiles in lung adenocarcinoma.肺腺癌中RNA编辑图谱的临床相关性。
Front Genet. 2023 Mar 10;14:1084869. doi: 10.3389/fgene.2023.1084869. eCollection 2023.
8
Epigenetic and Epitranscriptomic Control in Prostate Cancer.前列腺癌中的表观遗传和表观转录组学调控
Genes (Basel). 2022 Feb 18;13(2):378. doi: 10.3390/genes13020378.
9
ADAR1-mediated RNA editing links ganglioside catabolism to glioblastoma stem cell maintenance.ADAR1 介导的 RNA 编辑将神经节苷脂代谢与神经胶质瘤干细胞维持联系起来。
J Clin Invest. 2022 Mar 15;132(6). doi: 10.1172/JCI143397.
10
Targeting RNA editing of antizyme inhibitor 1: A potential oligonucleotide-based antisense therapy for cancer.靶向抗酶抑制剂 1 的 RNA 编辑:一种基于寡核苷酸的癌症潜在反义治疗方法。
Mol Ther. 2021 Nov 3;29(11):3258-3273. doi: 10.1016/j.ymthe.2021.05.008. Epub 2021 May 8.

本文引用的文献

1
Protein detection in gels using fixation.使用固定法进行凝胶中的蛋白质检测。
Curr Protoc Protein Sci. 2002 Nov;Chapter 10:10.5.1-10.5.18. doi: 10.1002/0471140864.ps1005s29.
2
Persistent use of "false" cell lines.持续使用“错误的”细胞系。
Int J Cancer. 2008 Jan 1;122(1):1-4. doi: 10.1002/ijc.23233.
3
Redirection of silencing targets by adenosine-to-inosine editing of miRNAs.通过微小RNA的腺苷到肌苷编辑实现沉默靶点的重定向。
Science. 2007 Feb 23;315(5815):1137-40. doi: 10.1126/science.1138050.
4
Androgen receptor and prostate cancer.雄激素受体与前列腺癌。
Prostate Cancer Prostatic Dis. 2007;10(2):114-8. doi: 10.1038/sj.pcan.4500936. Epub 2007 Feb 13.
5
Editor meets silencer: crosstalk between RNA editing and RNA interference.编辑与沉默者相遇:RNA编辑与RNA干扰之间的相互作用
Nat Rev Mol Cell Biol. 2006 Dec;7(12):919-31. doi: 10.1038/nrm2061.
6
Annotation, submission and screening of repetitive elements in Repbase: RepbaseSubmitter and Censor.Repbase中重复元件的注释、提交和筛选:RepbaseSubmitter和Censor。
BMC Bioinformatics. 2006 Oct 25;7:474. doi: 10.1186/1471-2105-7-474.
7
Identification of putative androgen receptor interaction protein modules: cytoskeleton and endosomes modulate androgen receptor signaling in prostate cancer cells.潜在雄激素受体相互作用蛋白模块的鉴定:细胞骨架和内体调节前列腺癌细胞中的雄激素受体信号传导
Mol Cell Proteomics. 2007 Feb;6(2):252-71. doi: 10.1074/mcp.M600169-MCP200. Epub 2006 Oct 18.
8
Androgen receptor as a licensing factor for DNA replication in androgen-sensitive prostate cancer cells.雄激素受体作为雄激素敏感性前列腺癌细胞中DNA复制的许可因子。
Proc Natl Acad Sci U S A. 2006 Oct 10;103(41):15085-90. doi: 10.1073/pnas.0603057103. Epub 2006 Oct 2.
9
Androgen receptor remains critical for cell-cycle progression in androgen-independent CWR22 prostate cancer cells.雄激素受体对雄激素非依赖性CWR22前列腺癌细胞的细胞周期进程仍然至关重要。
Am J Pathol. 2006 Aug;169(2):682-96. doi: 10.2353/ajpath.2006.051047.
10
PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor.PC3人前列腺癌细胞保留了雄激素受体发挥肿瘤抑制能力所需的共调节因子,而DU145人前列腺癌细胞则不然。
Prostate. 2006 Sep 1;66(12):1329-38. doi: 10.1002/pros.20483.